Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaExenatide

Exenatide

GLP-1 receptor agonist

Prescription medicine

What it is

An earlier-generation GLP-1 receptor agonist used in type 2 diabetes.

What the evidence shows

Well-studied for its registered diabetes indications.

Safety & reported risks

Gastrointestinal side effects are common; use is prescriber-managed.

Status in Australia

A registered prescription medicine for diabetes; availability of specific brands has varied over time.

How it’s lawfully accessed

Prescription and pharmacy dispensing of the registered product.

Related peptides

LiraglutideGLP-1 receptor agonistPrescription medicineSemaglutideGLP-1 receptor agonistPrescription medicineDulaglutideGLP-1 receptor agonistPrescription medicine

Sources & further reading

This entry is general information about Exenatide, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.